Musician Cyndi Lauper was afraid to show her skin and speaks about how painful her psoriasis was. With the help of Cosentyx, she's been clear for over four years and doesn't really think about her skin condition anymore.

Real COSENTYX users like Lauralee, Gary and Cyndi Lauper describe how they look and feel since using COSENTYX for their psoriasis. They encourage you to review the side effects and consult with a dermatologist if you think COSENTYX is for you.

Lauper was in a relationship from 1982 to 1988 with her then manager, Dave Wolff and has been married to actor David Thornton since 1991. They have one son, born on November 19, 1997. She has openly discussed her psoriasis, including in advertisements for Cosentyx.

COSENTYX TV Spot, 'Enough' Featuring Cyndi Lauper.

Bottoms of feet. More than half of people on COSENTYX were clear or almost clear on their scalp as early as 12 weeks compared to 6% taking placebo. Nail psoriasis improved by more than 46% in people receiving COSENTYX compared to an improvement of about 12% in people receiving placebo at week 16.

The list (or wholesale) price for COSENTYX, as of January 2023 is $6,924.26 a month for either 150-mg or 300-mg dose strength self-injection packages. The list price may not reflect the price paid by patients; most patients with prescription coverage will pay less. A month is defined as once every 4 weeks.

COSENTYX is designed to target and block IL-17A, which is believed to play a role in inflammation that causes psoriasis plaques and joint pain in people with psoriatic arthritis.

Development timeline for Cosentyx

The list (or wholesale) price for COSENTYX, as of January 2023 is $6,924.26 a month for either 150-mg or 300-mg dose strength self-injection packages. The list price may not reflect the price paid by patients; most patients with prescription coverage will pay less. A month is defined as once every 4 weeks.

Carolyn Dante is the girl belly dancing in the pink T-shirt who appeared in the Humira commercial, "Body of Proof, Drums" released on January 19th, 2021.

Secukinumab is a drug that reduces the signs and symptoms of psoriatic arthritis, ankylosing spondylitis, and psoriasis. Secukinumab is commonly known as Cosentyx®.

Real-World Data Suggest Long-Term Treatment With Secukinumab Is Safe, Effective. Findings are based on a retrospective, multicenter study carried out in Spain. New research details the long-term safety and efficacy of secukinumab in bio-naïve patients with moderate to severe cutaneous psoriasis.